Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Nitrolingual, and what substitute generic drugs are available?

Nitrolingual is a drug marketed by Pohl Boskamp and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.

The generic ingredient in NITROLINGUAL is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the nitroglycerin profile page.

Summary for Tradename: NITROLINGUAL

Suppliers / Packagers: see list4
Bulk Api Vendors: see list16
Clinical Trials: see list1
Patent Applications: see list2,292
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NITROLINGUAL at DailyMed

Pharmacology for Tradename: NITROLINGUAL

Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pohl Boskamp
AEROSOL;SUBLINGUAL018705-001Oct 31, 1985DISCNNoNo► Subscribe► Subscribe
Pohl Boskamp
SPRAY, METERED;SUBLINGUAL018705-002Jan 10, 1997RXYesYes7,872,049► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: NITROLINGUAL

Drugname Dosage Strength RLD Submissiondate
nitroglycerinSublingual Spray400 mcg/spray, 4.9 g and 12 g bottlesNitrolingual Pumpspray4/17/2012
nitroglycerinSublingual Spray400 mcg/spray, 4.9 g and 12 g bottlesNitrolingual Pumpspray8/23/2012
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.